Ivey-Miranda Juan B, Rao Veena S, Cox Zachary L, Moreno-Villagomez Julieta, Ramos Mastache Daniela, Collins Sean P, Testani Jeffrey M
Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, USA.
Department of Heart Failure, Hospital de Cardiologia, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Eur Heart J. 2025 Jul 1;46(25):2410-2418. doi: 10.1093/eurheartj/ehaf268.
Limited data are available to assess oral diuretic response in outpatients with heart failure (HF). The natriuretic response prediction equation (NRPE) predicts natriuresis following a loop diuretic dose using a urine sample 2 h after the dose and was validated to accurately predict intravenous diuretic response. The primary aim was to validate the NRPE's assessment of oral diuretic response in patients with HF.
The NRPE was evaluated in two HF patient cohorts receiving oral loop diuretics: Mechanisms of Diuretic Resistance (MDR) and TRANSFORM-Mechanism. Participants received their home oral loop diuretic followed by a supervised timed urine collection including spot urine samples at 1 and 2 h. Patients quantified their self-assessed diuretic response (urine volume) via a standardized survey. A poor diuretic response was defined as cumulative natriuresis < 50 mmol over the study visit.
The MDR cohort included 318 oral diuretic administrations from 237 patients. The NRPE predicted a poor natriuretic response with an area under the curve (AUC) of .87 [95% confidence interval (CI) .83-.91] and similar accuracy to the previously validated intravenous NRPE performance (P = .16). Patient's ability to self-estimate their diuretic response was poor with an AUC of .57 (95% CI .44-.70) and significantly worse than the oral NRPE (P < .001). In TRANSFORM-Mechanism (110 oral diuretic administrations), the NRPE had similar operating characteristics (AUC .89, 95% CI .80-1.0) for poor diuretic response.
Natriuretic response to an oral diuretic can be rapidly and accurately assessed with a urine sample collected 2 h after an oral diuretic dose and the NRPE.
评估心力衰竭(HF)门诊患者口服利尿剂反应的数据有限。利钠反应预测方程(NRPE)使用给药后2小时的尿液样本预测襻利尿剂剂量后的利钠作用,并已得到验证可准确预测静脉利尿剂反应。主要目的是验证NRPE对HF患者口服利尿剂反应的评估。
在两个接受口服襻利尿剂的HF患者队列中评估NRPE:利尿剂抵抗机制(MDR)和TRANSFORM - 机制。参与者服用其家用口服襻利尿剂,随后进行监督下的定时尿液收集,包括1小时和2小时的即时尿液样本。患者通过标准化调查量化其自我评估的利尿剂反应(尿量)。利尿剂反应不佳定义为在研究访视期间累积利钠量<50 mmol。
MDR队列包括来自237例患者的318次口服利尿剂给药。NRPE预测利钠反应不佳的曲线下面积(AUC)为0.87 [95%置信区间(CI)0.83 - 0.91],与先前验证的静脉内NRPE性能的准确性相似(P = 0.16)。患者自我估计利尿剂反应的能力较差,AUC为0.57(95% CI 0.44 - 0.70),明显低于口服NRPE(P < 0.001)。在TRANSFORM - 机制(110次口服利尿剂给药)中,NRPE对利尿剂反应不佳具有相似的操作特征(AUC 0.89,95% CI 0.80 - 1.0)。
口服利尿剂剂量后2小时收集尿液样本并使用NRPE可快速准确地评估口服利尿剂的利钠反应。